Document is current
Any future updates will be listed below
-
Authors
Ren, Yongqi
Cao, Li
Ren, Chongyang
Liu, Nanqiu
Wang, Siqi
Deng, Shuxuan
He, Yan
Li, Cheukfai
Li, Kai
Mok, Hsiaopei
Wen, Lingzhu
Wang, Yulei
Zhang, Xueying
Balch, Charles M.
Weitzel, Jeffrey N.
Zhang, Guochun
Wu, Jiayan https://orcid.org/0000-0001-6048-405X
Liao, Ning
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81001189)
National Natural Science Foundation of China (81071851)
Natural Science Foundation of Guangdong Province (2018A030313292)
Natural Science Foundation of Guangdong Province (2016A030313768)
Guangzhou Municipal Science and Technology Project (201804010430)
Guangzhou Municipal Science and Technology Program key projects (201707010418)
China Anti-Cancer Association-HER2 Target China Scientific Research Fund (CORP-239-S24)
- License Information
-
More Information
Article History
Received: 23 December 2025
Accepted: 14 April 2026
First Online: 28 April 2026
Declarations
:
: The present study was approved by the Ethics Committee at Guangdong Provincial People’s Hospital (Nos. KY2025-959-01). The patient signed a written informed consent for participation. This study adhered to the Declaration of Helsinki. This study was conducted in accordance with relevant institutional and national guidelines for research on human genetic data. All identifying and sensitive information was removed from the data prior to analysis, ensuring complete anonymization. No ethical or regulatory conflicts apply due to the use of fully de-identified data.
: Not applicable, as the study does not include any identifiable images or personal data.
: The authors declare no competing interests.
